Sam Strickson
BioPharmaceuticals R&D, AstraZeneca
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.
Journal: Mucosal immunology
Published: October 07, 2025
Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.
Journal: Mucosal immunology
Published: October 07, 2025
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.
Journal: The Lancet. Respiratory medicine
Published: March 11, 2025
Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture.
Journal: Scientific reports
Published: September 01, 2023
Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex.
Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex.
Journal: The European respiratory journal
Published: November 17, 2022
Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
Journal: PloS one
Published: July 29, 2021
Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 14, 2017
The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways.
Journal: Cell death and differentiation
Published: October 11, 2016
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
Journal: Scientific reports
Published: October 19, 2015
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 30, 2013
The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system.
Journal: The Biochemical journal
Published: February 28, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026